Patient Education Blog

Arixtra (Fondaparinux), Generic

“Is generic Arixtra as safe and effective as brand Arixtra?” a patient asks.  Answer: Yes.

Generic fondaparinux made by Dr. Reddy’s Laboratories Ltd. was approved by the FDA on July 11, 2011 (announcement about approval here).  Fondaparinux (Arixtra) is a once daily blood thinner (anticoagulant) that is injected underneath the skin. It can be given

  • for DVT prevention at a lower, i.e. prophylaxctic, dose, or
  • for treatment of DVT and PE at a higher, i.e;. at full therapeutic dose in the first few days when warfarin is being started, or
  • as an alternative to warfarin in patients who have had recurrent clots in spite of adequate INR values on warfarin (i.e. in patients in whom warfarin has failed).

Disclosure: I have no conflict of interest relevant to this post.

Last updated: Sept 26th, 2011

Disclaimer:  ClotConnect.org, its contributors, authors, advisors, members and affiliate organizations do not assume any liability for the content of the website, blog and educational materials. Medical information changes rapidly. While information is believed to be correct, no representation is made and no responsibility is assumed for the accuracy of information contained on or available through this website and blog. Information is subject to change without notice.

Tags: , , ,

Comments are closed.